MedPath

Diabetes Management Intervention For South Asians

Not Applicable
Completed
Conditions
HbA1c
Diabetes
Registration Number
NCT03333044
Lead Sponsor
NYU Langone Health
Brief Summary

The goal of this study is to evaluate the effectiveness and implementation process of a multi-level, integrated intervention to decrease HbA1c among South Asians with uncontrolled diabetes, including four components: 1) an EHR-based registry function to increase identification of South Asian patients with uncontrolled diabetes; 2) CHW-led health coaching of registered patients to promote health behavior change; 3) HIT-enabled and CHW-facilitated identification and referral to culturally relevant community resources for patients; and 4) HIT-enabled care coordination between the CHW and other members of the healthcare team.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
859
Inclusion Criteria
  • South Asian ethnicity (identified through a race and language code available in the EHR);
  • an appointment with a physician for routine non-emergent primary care in the last 12 months
  • diagnosis of diabetes
  • an HbA1c reading of >7 in the last 12 months
Exclusion Criteria
  • Pregnant women and visits to obstetrician/gynecologist are excluded from the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Percentage of Participants who had a 0.5% reduction in HbA1cBaseline, Month 6

Measured via complete lipoprotein panel.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

One Park Avenue

🇺🇸

New York, New York, United States

One Park Avenue
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.